Independent post-deployment assurance for clinical AI. Detect meaningful changes in scores, recommendations, actions, and clinical pathways before delayed outcomes reveal a larger problem.
Laitent monitors diagnostic models, clinical copilots, and emerging AI agents across software updates, device changes, workflow shifts, and patient populations.
Example: scored clinical AI. Watch only the count above the threshold and this looks stable. Every score rose about 9 percent; at the threshold that shows up as almost nothing.
For generative AI, Laitent applies the same principle to recommendations, pathways, omissions, and output concentration.
Clinical AI is validated at one point in time. The clinical environment continues changing afterward. Software updates, devices, workflows, and patient populations can all shift.
Uptime checks and vendor dashboards show whether a system is available. They do not show whether its behavior has changed. Clinical confirmation often arrives later through pathology, follow-up, adjudication, or chart review. Laitent provides an earlier, independent signal for validation and change control.
Laitent detects the first two links from de-identified AI outputs. Accuracy loss and clinical impact require later confirmation through pathology, follow-up, adjudication, or chart review. The dashed line marks that confirmation gap.
Laitent works alongside existing quality assurance, vendor monitoring, and AI governance. It evaluates whether deployed systems continue to behave as expected across sites, devices, workflows, patient populations, and model versions, from scored outputs to generated recommendations and agent actions.
Diagnostic AI produces scores. Clinical copilots produce recommendations. AI agents can take or initiate actions. Each requires a deeper level of post-deployment supervision before outcomes are available to confirm the effect.
Scanner, protocol, density mix, and software version shifts can move score distributions.
Ground truth lag
Pathology and interval-cancer follow-up.
Stain, scanner, tissue prep, and lab workflow can shift tumor or grade scores.
Ground truth lag
Pathologist review and downstream outcomes.
Camera model, operator technique, and site mix can move referable-disease scores.
Ground truth lag
Specialist adjudication and follow-up.
Documentation, coding, staffing, and EHR-version changes can move risk scores.
Ground truth lag
Clinical deterioration and outcome review.
Scanner, protocol, site mix, and referral pattern changes can alter triage score streams.
Ground truth lag
Confirmatory reads and downstream outcomes.
Evaluate whether recommendations and actions remain guideline-grounded, appropriately broad, consistent over time, and within approved clinical and escalation boundaries.
Recommendation and action assurance
Pathway coverage, omissions, action limits, longitudinal consistency, and escalation behavior.
Laitent currently applies this approach to diagnostic and generative clinical AI outputs. Clinical agents extend the same assurance requirement from monitoring outputs to supervising sequences of recommendations and actions.
Research and real world deployments show that model behavior can change after software, equipment, workflow, or population shifts. They also show why monitoring should be proactive and pre-specified.
revealed a distribution shift requiring threshold recalibration
Diagnostic accuracy, fairness and clinical implementation of AI for breast cancer screening · Kelly et al., Nature Cancer, 2026
sensitive to changes in the environment and liable to performance decay
Clinical artificial intelligence quality improvement · Feng et al., npj Digital Medicine, 2022
Manual review is difficult to scale and can delay recognition of meaningful changes.
How do radiologists currently monitor AI in radiology, and what challenges do they face? · Chow et al., J. Imaging Informatics in Medicine, 2025
define metric-specific alert thresholds in advance
Monitoring deployed AI systems in health care · Keyes et al., 2025 Preprint
a framework for data drift monitoring using Statistical Process Control (SPC) methods
Out of Distribution Detection and Radiological Data Monitoring Using Statistical Process Control · Zamzmi et al. (FDA CDRH), J. Imaging Informatics in Medicine, 2025
a software upgrade on the mammography equipment, requiring per software version thresholds
Impact of Different Mammography Systems on Artificial Intelligence Performance in Breast Cancer Screening · de Vries et al., Radiology: Artificial Intelligence, 2023
Compare current AI outputs against an established local baseline to identify meaningful behavioral changes before outcome data matures.
Stratified analysis narrows the search across site, device, acquisition source, software version, workflow, and patient mix so investigations begin in the right place.
Works from de-identified score exports. No images, no PHI, and no new infrastructure to stand up.
Output-integrity checks, score drift, threshold-neighborhood mass, and subgroup divergence are tracked across operational and patient mix levels. Subgroups are monitored as signals, not treated as proof of accuracy loss.
Audit-ready reports summarize what changed, where it changed, and what should be reviewed next without claiming confirmed accuracy loss.
Measure omissions, pathway coverage, recommendation concentration, escalation behavior, and action-pattern changes across prompts, models, and versions.
Clinical copilots can narrow the options presented to clinicians. Agentic systems add a deeper risk: individually plausible recommendations can become unsafe across a sequence of medication, scheduling, coaching, or escalation decisions. Laitent evaluates behavior across outputs, versions, patient scenarios, and longitudinal trajectories.
Which clinically reasonable diagnostic, treatment, or disposition routes remain represented?
Do recommendations and actions remain within approved clinical, medication, escalation, and workflow limits?
Do individually plausible decisions remain coherent and safe across a patient trajectory?
Did a model, prompt, policy, or workflow update shift recommendations, actions, or escalation behavior?
The monitoring depth increases with autonomy: scores → recommendations → actions. Laitent does not replace clinical oversight; it provides an independent signal when deployed behavior changes or crosses configured boundaries.
Provide de-identified baseline outputs, representative scenarios, action logs, or a defined reference period, along with available metadata such as site, device, model version, workflow, or patient population.
We compare current behavior with the baseline using predefined statistical and clinical criteria. For scored systems, this includes output distributions. For generative and agentic systems, it can include omissions, pathway coverage, boundary compliance, escalation behavior, and longitudinal consistency.
Receive prioritized findings, likely contributing factors, recommended follow-up, and an audit-ready report for AI governance and quality review.
Root cause categories we review
| Stratum | Examples | Why it matters |
|---|---|---|
| Acquisition or input source | Site, scanner, camera, stain, protocol, technologist group | Separates equipment, image acquisition, or input-source shifts from model behavior. |
| Software | AI model version, acquisition/reconstruction version, release date, export mapping | Separates a change in the model from a change in the images it reads. |
| Output integrity | Score presence, degenerate values, volume, operating point | Confirms the model is producing valid scores before any shift is read as drift. |
| Patient mix | Age, screening/diagnostic mix, risk mix, referral pattern | Distinguishes real population change from operational drift. |
| Density distribution | Category shares, B/C boundary share, assigner and its version | Assigned by a radiologist or by automated density software, so it can move independently of the AI model. Monitored as a signal, never used as a covariate. |
| Time window | Baseline, recent period, pre/post event | Localizes when the shift began and whether it was gradual or abrupt. |
Findings are supported by baseline comparison, distribution-shift tests, control limits, and trend/change point analysis. Stratified findings are gated on the aggregate: a within-stratum shift is never escalated on its own, because a stratum boundary that moves can manufacture drift where none exists.
An early warning layer that complements outcome-based QA and clinical AI governance.
"Every alert should tell you what changed, where it changed, and what to check next."
Every finding includes the size, location, and likely source of the change, not just a red light.
The monitoring approach uses statistical process control and thresholds defined in advance to produce repeatable, auditable findings.
Laitent establishes a defined local baseline, measures current AI behavior, and helps hospital teams identify meaningful changes after deployment or system updates.
Tell us about the AI system and the change or concern you want to evaluate. We will follow up to scope the assessment.